跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMBRISENTAN VIVANTA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
AMBRISENTAN VIVANTA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
AMBRISENTAN VIVANTA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 5, 2024
Approval ID
6d6ed5ba171e7aa2
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
6d6ed5ba171e7aa2
Drug Cima Aemps Name
AMBRISENTAN VIVANTA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
89411
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Vivanta Generics S.R.O. Sucursal En Espana
Authorization Date
2024-03-05
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Vivanta Generics S.R.O.
Active Ingredients
AMBRISENTAN
5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 5, 2024
Approval ID
6d6ed5ba171e7aa2
Type
Standard
Back to CIMA-AEMPS Approvals